Latest news with #Indiana-based
Global News
3 days ago
- Politics
- Global News
Kristi Noem unveils ICE detention centre coined the ‘Speedway Slammer'
U.S. Secretary of Homeland Security Kristi Noem announced Tuesday the opening of a new migrant detention centre, coined the Speedway Slammer, that will house 1,000 inmates detained as part of President Donald Trump's immigration crackdown. The Indiana-based facility, built in partnership with the state Department of Corrections, will hold 'some of the worst of the worst criminal illegal aliens arrested by ICE,' the Department of Homeland Security said in a statement on Tuesday. Noem announced the centre on X, saying, 'COMING SOON to Indiana: The Speedway Slammer. Today, we're announcing a new partnership with the state of Indiana to expand detention bed space by 1,000 beds,' she wrote. 'Thanks to @GovBraun for his partnership to help remove the worst of the worst out of our country. If you are in America illegally, you could find yourself in Indiana's Speedway Slammer,' she continued, adding that to avoid arrest, people residing illegally in the U.S. can self-deport.' Story continues below advertisement COMING SOON to Indiana: The Speedway Slammer. Today, we're announcing a new partnership with the state of Indiana to expand detention bed space by 1,000 beds. Thanks to @GovBraun for his partnership to help remove the worst of the worst out of our country. If you are in… — Kristi Noem (@KristiNoem) August 6, 2025 Indiana Gov. Mike Braun announced that the state would cooperate with Noem's department on Aug. 1, saying, 'Indiana is not a safe haven for illegal immigration. We will fully partner with federal immigration authorities as they enforce the most fundamental laws of our country.' Get breaking National news For news impacting Canada and around the world, sign up for breaking news alerts delivered directly to you when they happen. Sign up for breaking National newsletter Sign Up By providing your email address, you have read and agree to Global News' Terms and Conditions and Privacy Policy Following Noem's unveiling of the new facility, Braun told Fox News, 'We are proud to work with President Trump and Secretary Noem as they remove the worst of the worst with this innovative partnership. Indiana is taking a comprehensive and collaborative approach to combating illegal immigration and will continue to lead the way among states.' The 'Speedway Slammer' references one of Indiana's most famous attractions, the Indianapolis Motor Speedway. On Tuesday, the Department of Homeland Security shared an AI-generated image of an Indy 500 car, with the word 'ICE' (Immigration and Customs Enforcement) plastered across its livery, rushing past a looming concrete prison surrounded by barbed wire and watch towers. Story continues below advertisement The Speedway Slammer 🏁 — Homeland Security (@DHSgov) August 5, 2025 The owner of the Indianapolis Speedway, Penske Entertainment, told the IndyStar, that it was 'unaware of plans to incorporate our imagery as part of the announcement.' 'Consistent with our approach to public policy and political issues, we are communicating our preference that our IP not be utilized moving forward in relation to this matter,' the statement said. Its unveiling follows the opening of detention centre named 'Alligator Alcatraz' in Florida, another facility built by the Trump administration designed to house illegal migrants. Alligator Alcatraz, which has been condemned by critics as an inhumane makeshift prison camp, was praised by the president as a model for future nationwide facilities aimed at accelerating deportations, including possibly deporting U.S. citizens. Story continues below advertisement Trump, Noem and Florida Gov. Ron DeSantis said in July that the facility will soon 'handle the most menacing migrants, some of the most vicious people on the planet.' The president said the moniker is 'very appropriate because I looked outside and that's not a place I want to go hiking anytime soon.' — With files from Global News' Michelle Butterfield
Newsweek
3 days ago
- Business
- Newsweek
Donald Trump Threatens 250% Tariff on Pharmaceuticals
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. President Donald Trump has said that tariffs on pharmaceutical imports could eventually reach up to 250 percent, as his administration works to lower prescription prices for Americans. During an interview with CNBC on Tuesday, the president said he will initially impose a "small tariff on pharmaceuticals," which will rise to 150 percent "in one year, one and a half years maximum," before then eventually jumping to 250 percent. Newsweek reached out to the White House via email for comment. Why It Matters The United States imports a significant amount of pharmaceuticals each year—over $200 billion in 2024, according to the Observatory of Economic Complexity. Should Trump follow through on ramping up these duties, the highest he has threatened on the industry to date, experts believe this could result in significant increases to drug prices in the U.S. However, some health policy experts told Newsweek this could also help rebalance the global drug supply chain to better favor American customers. What To Know Trump said that the tariffs are intended to encourage pharmaceutical companies to move their operations to the U.S.—"because we want pharmaceuticals made in our country"—and to minimize reliance on Europe. He had previously threatened to place 200 percent tariffs on pharmaceuticals in July, but said he would give the industry time before this change came into effect. Trump's threats of pharmaceutical tariffs have raised concerns among experts that these could lead to increased costs and medication shortages in the U.S. In April, the UNC Center for the Business of Health published a report warning that these effects would be especially significant for generic drugs, which are more likely to be imported and operate on lower profit margins than brand-name medications. "A 250 percent tariff on pharmaceuticals would have a significant impact on drug prices," said health economist Jeromie Ballreich. Ballreich told Newsweek that, for branded pharmaceuticals, higher costs from the tariffs will be "passed on to consumers and most likely will be indirect through higher prescription drug insurance premiums." Major pharmaceutical companies across the world saw their shares fall on Wednesday following Trump's announcement. England-based AstraZeneca was down by 1.1 percent, Indiana-based Eli Lilly by 2.3 percent, and Germany-based Bayer AG by nearly 10 percent as of 11:20 ET. President Donald Trump speaks to reporters near Air Force One at Lehigh Valley International Airport on August 3, 2025. President Donald Trump speaks to reporters near Air Force One at Lehigh Valley International Airport on August 3, latest threat comes as the industry braces for the outcome of an ongoing probe by the Commerce Department into the national security implications of America's medicinal imports. The investigation was launched in April by Commerce Secretary Howard Lutnick under Section 232 of the 1962 Trade Expansion Act. Trump did not provide many specifics, such as whether certain classes of pharmaceuticals would be exempt, beyond stating that these tariffs are separate from the country-specific duties that came into effect last week. However, the announcement appears to contradict the terms of the European Union deal struck in July, which the European Commission president said placed a 15-percent tariff "ceiling" on multiple sectors, including pharmaceuticals. Experts had already warned that the 15 percent tariff outlined in the EU trade deal could end up costing the pharmaceutical industry billions. The cost implications could also be seen as conflicting with the administration's separate attempts to lower the price of prescription drugs. President of the European Commission Ursula von der Leyen meets with President Donald Trump in Turnberry, Scotland, on July 27, 2025. President of the European Commission Ursula von der Leyen meets with President Donald Trump in Turnberry, Scotland, on July 27, May, Trump signed an executive order directing the Secretary of Commerce and U.S. Trade Representative to "ensure foreign countries are not engaged in practices that purposefully and unfairly undercut market prices and drive price hikes in the United States." It also proposed that the U.S. be given Most-Favored-Nation (MFN) status, which would require drug companies to offer Americans the same lowest price that drugs are sold for in other countries. Trump followed this up by sending letters to 17 of the world's largest pharmaceutical companies on July 31, outlining steps they must take within 60 days to lower prescription prices for U.S. customers. These include extending MFN pricing to Medicaid, guaranteeing MFN pricing for new medications and negotiating "harder with foreign freeloading nations." The letters also call on the companies to expand direct-to-consumer distribution models to ensure customers "get the same low MFN prices that manufacturers already offer to third-party payers." "At face value, these tariffs are contradictory to his efforts to lower domestic prices," Ballreich told Newsweek. "However, if the tariffs are used as a threat to get drug companies to comply to his administration's [executive orders], including the recent letters to pharmaceutical CEOs, then I think we could see some changes to the pharmaceutical market, which will lower domestic drug prices." Several drugmakers, including Eli Lilly, AstraZeneca and Johnson & Johnson, have also pledged to expand their U.S. manufacturing presence. Prior to the letters being sent, but amid this pressure from the administration, a number had also announced they would be reducing some U.S. drug prices. Health policy analyst Mariana Socal warned that beyond potential cost implications, the tariffs could significantly disrupt the drug development pipeline, potentially jeopardizing the release of new medications. "Aside from the problem of added costs, the uncertainty introduced by tariff policies is detrimental in and of itself to the pharmaceutical market," she told Newsweek, noting that only around one in 10,000 investigated compounds make it to pharmacy shelves, and only do so after decades of work. "Any added uncertainty is likely to be detrimental to this industry, including disincentivizing investors from supporting this industry and pharmaceutical manufacturers from continuing to look for cures," she said. What People Are Saying Health economist Jeromie Ballreich told Newsweek: "This tariff could really disrupt the U.S. prescription drug market, especially the Medicare part D market, where the party plans will be on the hook for the higher price prices and result in significant premium increases to offset these higher prices. Given that, I don't think it's likely that this massive tariff will occur, but rather is a threat to force companies to find solutions based on the executive orders and his recent letters to pharmaceutical CEOs." Mariana Socal, an associate professor at the Johns Hopkins Bloomberg School of Public Health, told Newsweek: "It is critical to continue to identify solutions to lower drug prices in America and improve drug affordability for Americans. However, it is unclear how tariffs would advance affordability. On the opposite, tariffs can be understood as a hidden tax." "In the short term, the likelihood that added costs from tariffs will be passed through to consumers can be reduced by existing contractual agreements with supply chain participants such as distributors and group purchasing organizations, which can protect buyers from price increases for 1-3 years," she added. "However, even if the added cost of tariffs would not necessarily be passed-through to patients in the short term, it could raise costs in the long run." What Happens Next On Sunday, Trump said he would be announcing tariffs on the industry "within the next week or so."
San Francisco Chronicle
4 days ago
- Business
- San Francisco Chronicle
NiSource: Q2 Earnings Snapshot
MERRILLVILLE, Ind. (AP) — MERRILLVILLE, Ind. (AP) — NiSource Inc. (NI) on Wednesday reported earnings of $102.2 million in its second quarter. On a per-share basis, the Merrillville, Indiana-based company said it had net income of 22 cents. The energy holding company posted revenue of $1.28 billion in the period. _____
CNBC
4 days ago
- Business
- CNBC
Utilities are surging in 2025. Wall Street likes these dividend-paying stocks
Utilities are emerging as a hot play in 2025 as investors take notice of their role in powering the artificial intelligence movement – and many of the names also happen to pay attractive dividends. As the broader S & P 500 retreated on Tuesday, the Utilities Select Sector SPDR Fund (XLU) touched a fresh record. Utilities are the second-best performing sector in the S & P 500 in 2025, up more than 14% and outperforming tech's roughly 13% advance. The outperformance is greater still including utilities' 2.8% dividend yield. XLU 5D mountain The Utilities Select Sector SPDR Fund (XLU) in the past five days. "For the power sector we expect significant tailwinds in the second half of 2025," said Bank of America analyst Ross Fowler in a late June report, pointing to the likelihood of continued growth in electricity demand. "Despite significant positive returns so far this year, we continue to believe the power stocks have data center related catalysts across the second half." In addition, dividend-paying stocks are looking more favorable for investors who are on the prowl for income, anticipating the day when the yield on risk-free Treasurys declines. To that end, CNBC Pro used FactSet data to screen for names within the XLU ETF that have buy or overweight ratings from at least 51% of the analysts covering them, and a dividend yield of at least 1.5%. PPL Corp. turned up on CNBC's screen. Once known as Pennsylvania Power & Light, the utility's shares are up 10% in 2025, and the stock pays a current dividend yield of about 3%. The provider of power and natural gas in Pennsylvania, Kentucky, Rhode Island and Virginia reported adjusted earnings of 32 cents on revenue of $2.03 billion in the second quarter against consensus estimates of 39 cents a share and $1.81 billion in revenue. Nearly 59% of the analysts covering the PPL rate it buy, according to FactSet. Jefferies analyst Paul Zimbardo stuck with the stock, reiterating a "buy" rating and lifting his price target on Monday by $2, to $42, suggesting 16% upside from Monday's close. "PPL is one of our top utility ideas, offering under-appreciated regulated generation data center exposure with premium core utilities overall," he said. "PPL has visibility to 8% EPS growth with conservative assumptions while preserving an above-average balance sheet." The icing on the cake is a recently announced joint venture between PPL and Blackstone Infrastructure to build natural gas generation to power data centers. "It is clear that this is an early stage partnership, but there is real option value here," Zimbardo said. NiSource also turned up on the screen. More than seven out of 10 analysts covering the Indiana-based utility recommend it as a buy or overweight, according to FactSet. Shares are up 16% in 2025, and the stock pays a current dividend in 2.6%. Fowler of Bank of America reiterated a buy rating on NiSource in late June following meetings with top brass. "NI is fielding active interest from hyperscalers seeking sites in Northern Indiana, where fiber and transmission access are gating factors," the analyst wrote. "A large fiber network from Chicago through northwest Indiana enhances competitiveness." "Paired with a solid dividend and visible [free cash flow] growth, we view NI as a defensive name with embedded optionality from growth upside," Fowler said. Finally, Xcel Energy turned up on our screen. The Minneapolis-based stock has a following, with 65% of analysts rating it a buy or overweight, according to FactSet. Shares are up 9% in 2025, and the stock pays a current dividend yield of about 3.1%. Anthony Crowdell of Mizuho last week stuck with his "outperform" rating after Xcel posted second-quarter results that topped the Street's estimates. "The company now has visibility into $15B+ of additional [capital expenditures] not included in its current base plan," he said. "This includes generation capex from resource plans across its service areas, transmission and data center demand." With the increase in capital spending built into the rate base, "the company reaffirmed its long-term EPS growth rate of 6%-8% and continue to expect to be in the upper half of the range," Crowdell added. — CNBC's Michael Bloom contributed reporting.
Irish Examiner
26-07-2025
- Entertainment
- Irish Examiner
Indianapolis: Exploring the home of speed, sport and sass
Back when I lived in New York, a friend of mine would introduce herself as being from Indynoplace — a cheeky, eye-roll nickname for Indianapolis, the kind of city that barely prompted a reaction. You could file Indiana's capital under 'fine' — all flat vowels, flat land and, according to the haters, flat vibes. So what's Aer Lingus doing launching a slick new direct flight there four times a week on a single-aisle A321neo? Here's a clue: Indianapolis also goes by the 'Crossroads of America.' It's laced into a criss-cross of interstates, within easy reach of cities such as Cincinnati, Columbus, St Louis, Chicago, and Louisville. It's the kind of place that makes sense on a map, a strategic stop where your road trip playlist barely gets going before you've arrived somewhere else. But there's more to it than logistics. This is the first direct connection between Indy and Europe, and with more than 50 Indiana-based companies linked to Ireland, the economic logic is sound. For Aer Lingus, it's a chance to boost Dublin's role as a gateway to the American Mid-West. For Hoosiers, it's a shortcut to the other side of the Atlantic. Still, Indy isn't just playing middleman. The city's quietly upping its game, with eye-catching murals, small-batch breweries, boundary-pushing kitchens and a homegrown creative streak that's giving it a new edge. Maybe Indynoplace is due a bit more attention after all. The surest way to get the measure of a city is on foot — or better still, on two wheels. Indy's eight-mile Cultural Trail snakes through six downtown districts, threading Mass Ave, White River State Park and Fountain Square into one seamless loop. Expect bursts of public art at every turn (Ann Dancing, Julian Opie's LED stick-figure in the Mass Ave district is a highlight) and a stop-you-in-your-tracks landmark in the Madam Walker Legacy Center, a 1927 Art Deco theatre honouring America's first black female millionaire. Tucked just off Indiana Avenue, the Kurt Vonnegut Museum and Library is part gallery, part shrine, part gentle rebellion — a fitting tribute to Indy's most subversive literary son. Founder Julia Whitehead champions the museum's unapologetic stance on free speech, arguing that its independence from federal funding gives it the freedom to speak louder — and braver — than many larger institutions. Vonnegut, no fan of censorship, would no doubt be cheering from the rafters. His words on the subject are on display here, more urgent now than ever. At 10th and Lewis Streets, the Cultural Trail plugs into the 26-mile Monon Trail, a reclaimed rail corridor that shoots north through hip Broad Ripple — student nightlife on tap — before rolling past elegant Carmel's manicured lawns and all the way to Sheridan in central Indiana. Breweries spill onto the path here too, whether you're chasing small-batch sours in Fountain Square or a post-pedal pint on Mass Ave. Race day at the Speedway, Indianapolis THE INDY 500 All of Indianapolis's low-key cool gets left in the dust once you hit the northwest side of town. Indy's other persona is 'The Racing Capital of the World'. The Indianapolis Motor Speedway plays host to a full calendar of high-octane events, but it all builds to one roaring crescendo: The Indy 500. Held every Memorial Day weekend, it draws a jaw-dropping 340,000 fans, packing out the biggest sports venue on the planet. It's loud, it's legendary, and it's pure, unfiltered adrenaline. If you're not in town for race day, don't worry — the newly revamped museum does a solid job of capturing the buzz, with exhibits that bring the drama and speed to life. Fionn Davenport on the podium at Indianapolis Speedway Guided tours take you behind the scenes of one of America's most-watched sporting events, all the way onto the legendary track, where you can channel your inner champion and plant a kiss on the famous Yard of Bricks, the iconic start-finish line and the last visible stretch of the original 4km brick-paved surface that earned the Speedway its nickname, 'the Brickyard'. On the way to the track, I made the obligatory pilgrimage to Long's Bakery because apparently, no Speedway trip is legit without it. From the outside, it's all no-frills charm: A plain facade straight out of 1955. They specialise in donuts that don't need fanfare. Just glossy glaze, pillowy dough, and maybe a hit of jelly or custard if you're feeling fancy. The coffee is jet black and no nonsense (I heard someone ask for a cappuccino and they were almost laughed out of the place). They're proudly cash-only, a pleasing anachronism in a world of tap-and-go. It's all part of the magic. The Bottleworks district Not that Indianapolis can't do sophisticated. Step off Mass Ave and you'll hit one of Indy's freshest playgrounds, located around what was once the world's largest Coca-Cola bottling plant. The Art Deco sprawl still covers multiple blocks, but now its old garage thrums as a food hall where more than 20 vendors dish up globe-trotting comfort. Picture Greek pitas from Mama Fofo, chimichurri-soaked Brazilian steak sandwiches, and Mid-West crowd-pleasers — smoky ribs from Pig Pen and nostalgia-laden burgers at Clancy's, still flipped to Carl Fogelsong's 1965 recipe. Directly opposite, the plant's main building has re-emerged as the Bottleworks Hotel, all soaring ceilings, terrazzo floors, and graceful curves. The Art Deco bones remain intact, but tech-smart touches bring the whole place neatly into the now. One place that has remained more or less unchanged is St Elmo, a carnivore haven that is one of the city's last true independent steakhouses. This 120-year-old spot racks up awards for service, romance, and white-tablecloth flair, but the main reason to come is to sink your teeth into prime, perfectly charred beef, and challenge yourself to its signature shrimp cocktail — a fire-breathing starter made with lots and lots of horseradish that lights up your sinuses. St Elmo's Steakhouse ST ELMO'S FIRE The walls of St Elmo's are lined with portraits of famous patrons and sports stars, including plenty of local heroes. The Colts — among the NFL's oldest franchises — made the move from Baltimore in 1983, and now call Lucas Oil Stadium home. You can even take a tour if you're into gridiron cathedrals. But if football's a passion, basketball is religion. Hoosier Hysteria runs deep in the state. Gainbridge Fieldhouse, smack in the middle of downtown (and also worth a tour), hosts the Indiana Pacers (at the time of writing playing in their first NBA finals since 2000) and the Indiana Fever — now packing in crowds thanks to Caitlin Clark, the phenom redefining women's basketball in real time. Victory Field is home to the minor league Indianapolis Indians and serves up pure Americana: Summer nights, cheap bleacher seats, hot dogs in hand and a beer under the lights. It's as close as you'll get to Field of Dreams without stumbling into a cornfield. I only had three days on the ground, but Indy made its case fast. The new Aer Lingus hop is more than a convenient doorway to the Mid-West — it's an invitation to linger. Give the city a couple of days and you'll see why it earns a place on the itinerary, and not just the map. THREE PLACES TO EAT The Garage Food Hall: 20+ vendors selling all kinds of cuisine, from burgers to bao buns. You can eat well here for around $20 St Elmo's Indianapolis' most famous restaurant is an old-school steakhouse, but its signature dish is its super-hot shrimp cocktail starter. Milktooth: For the trendiest breakfast in town, this tchotchke-filled spot tacks hard between tasty and artsy. OUTLAW SPIRIT Indy's bar scene is stacked, yet the Slippery Noodle Inn still steals the spotlight. Open since 1850, the place has worn many hats – brothel, slaughterhouse, speakeasy – and counted hometown outlaw John Dillinger among its regulars (look for the bullet holes in one of the walls). During the Civil War its basement sheltered freedom- seekers on the Underground Railroad, a slice of history you can still step into. These days it's straight-up bar meets live-music haven – no frills but plenty of tall tales between pitchers of local brew. A room at Bottleworks Hotel ESCAPE NOTES Aer Lingus flies four times weekly with fares from €250 each way, Bottleworks Hotel rooms from $179, Kurt Vonnegut Museum and Library admission $12, Indianapolis Motor Speedway Museum admission $25; track tours $15-55, Lucas Oil Stadium tour $20, Gainbridge Fieldhouse tour from $10 per person, Victory Field (Indianapolis Indians), tickets from $15,
